首页> 美国卫生研究院文献>Springer Open Choice >Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort
【2h】

Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort

机译:在哮喘的流行病学和自然史中评估哮喘控制和哮喘加重的疗效:观察结果和治疗方案(TENOR)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Patients with severe or difficult-to-treat asthma account for substantial asthma morbidity, mortality, and healthcare burden despite comprising only a small proportion of the total asthma population. TENOR, a multicenter, observational, prospective cohort study was initiated in 2001. It enrolled 4,756 adults, adolescents and children with severe or difficult-to-treat asthma who were followed semi-annually and annually for three years, enabling insight to be gained into this understudied population. A broad range of demographic, clinical, and patient self-reported assessments were completed during the follow-up period. Here, we present key findings from the TENOR registry in relation to asthma control and exacerbations, including the identification of specific subgroups found to be at particularly high-risk. Identification of the factors and subgroups associated with poor asthma control and increased risk of exacerbations can help physicians design individual asthma management, and improve asthma-related health outcomes for these patients.
机译:尽管仅占总哮喘人口的一小部分,但患有严重或难以治疗的哮喘的患者仍占很大的哮喘发病率,死亡率和医疗保健负担。 TENOR是一项多中心,观察性,前瞻性队列研究,于2001年启动。该研究招募了4756名成年人,青少年和患有严重或难以治疗的哮喘的儿童,每半年和每年进行一次随访,为期三年,从而使您能够深入了解这个人口不足的人群。在随访期间完成了广泛的人口统计学,临床和患者自我报告评估。在这里,我们介绍了来自TENOR注册中心的有关哮喘控制和加重的关键发现,包括鉴定发现的特别高危人群。识别与哮喘控制不佳和加重发作风险增加相关的因素和亚组,可以帮助医生设计个体哮喘管理方法,并改善这些患者与哮喘相关的健康状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号